Effective April 6, 2022, Shefali Agarwal, the Executive Vice President, Chief Medical and Development Officer of Epizyme, Inc. resigned from the Company to pursue other business opportunities. Following her resignation, Dr. Agarwal will serve as a senior medical consultant to the Company and, in that capacity, as the Company's acting Chief Medical and Development Officer.